| Status: Medicine does not meet criteria for AWMSG assessment | |
Excluded from appraisal by AWMSG as meets exclusion criteria 5. See AWMSG criteria for appraising a medicine (PDF, 430Kb) for information. |
|
Medicine details |
|
| Medicine name | telmisartan/amlodipine (Twynsta®) |
| Formulation | tablet |
| Reference number | 815 |
| Indication | As an add on therapy for the treatment of essential hypertension in adults whose blood pressure is not adequately controlled on amlodipine and replacement therapy for the treatment of essential hypertension in adults already receiving telmisartan and amlodipine from separate tablets |
| Company | Boehringer Ingelheim Ltd |
| BNF chapter | Cardiovascular system |
| Submission type | N/A |
| Status | Medicine does not meet criteria for AWMSG assessment |
| Date of issue | 08/04/2011 |